Sponsors (2)
The bill strengthens and steadies funding and oversight for Medicare/Medicaid fraud detection—improving program integrity and transparency—but increases federal spending and risks greater administrative and compliance burdens for providers, with CPI‑indexing locking in future spending growth.
Medicare beneficiaries and taxpayers: receive larger, multi‑year, predictable Medicare Integrity Program funding ($1.28B FY2027; $1.38B FY2028; $1.48B FY2029) with CPI‑U indexing after FY2029 to sustain fraud‑detection and program‑integrity activities.
Hospitals, health systems, and Medicare/Medicaid programs: get strengthened fraud‑fighting capacity through increased DOJ/HHS OIG program integrity pools (multi‑year increases) that improve investigation and enforcement resources.
State governments, hospitals, and taxpayers: benefit from increased funding for Medicare–Medicaid (and related) data‑matching ($110M FY2027; $120M FY2028; $130M FY2029) to better identify improper payments across programs.
Taxpayers: face higher federal spending and potential increased deficit pressure because the bill enacts sustained, larger funding levels for program‑integrity activities.
Hospitals, health systems, and state agencies: will likely experience more audits, data‑matches, and administrative burden as enforcement and data‑matching activities expand.
Providers and Medicaid beneficiaries: could face more investigations, payment delays, and higher provider compliance costs as investigatory activity and stricter enforcement increase.
Based on analysis of 3 sections of legislative text.
Raises statutory funding caps for Medicare anti-fraud programs for FY2027–FY2029 with CPI-U indexing thereafter and mandates a GAO study of HCFAC performance.
Official title: To amend title XVIII of the Social Security Act to strengthen program integrity oversight for the Health Care Fraud and Abuse Control Program, and for other purposes.
Introduced September 10, 2026 by Thomas Suozzi · Last progress September 10, 2026
Increases statutory funding limits for federal health care fraud prevention and enforcement programs tied to Medicare, including higher dollar caps for HHS program integrity, the HHS Office of Inspector General (OIG), and related DOJ/FBI activities for fiscal years 2027–2029, and requires those limits to be indexed to annual CPI-U increases after FY2029. Requires the Government Accountability Office (GAO) to study the Health Care Fraud and Abuse Control (HCFAC) Program and report findings and recommendations to Congress within 16 months.